# AMN Healthcare Services Inc (AMN) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Healthcare / Health Care Equipment & Supplies. Price $33.80, market value $1.3 billion.

## Valuation
- **P/E (trailing): 12.6×** (5-yr avg 14.1×, 3-yr avg 14.0×). AMN Healthcare Services Inc trades at 12.6× trailing earnings, close to its own five-year average of 14.1×. The Healthcare median in the September 2026 study was 28.5×. Forward P/E is 36.1×, higher than trailing, so analysts expect earnings to fall.
- **PEG: 1.01**. A PEG of 1.01 is in the range usually read as fairly priced for its growth.
- **Price / sales: 0.4×**. Each dollar of revenue is priced at 0.4×, a low multiple typical of thin-margin businesses or out-of-favour stocks.
- **Price / book: 1.8×**. The shares trade at 1.8× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 5.9×**. Enterprise value is 5.9× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 33.5%** (5-yr avg 18.1%). Free cash flow equals 33.5% of the market value, above its five-year average of 18.1%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 8.0%**. The inverse of the P/E: 8.0% of the price is earned each year.

## Profitability
- **Gross margin: 27.8%**. AMN Healthcare Services Inc keeps 27.8% of revenue after the direct cost of what it sells.
- **Operating margin: 5.8%**. 5.8% of revenue is left after running the business.
- **Net margin: -3.5%**. The company reported a net loss over the last twelve months.
- **Return on equity: -14.9%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: 11.5%**. Return on all capital, debt included, is 11.5%.
- **Return on assets: 5.0%**. Each dollar of assets produces 5.0% of profit.

## Growth
- **Revenue growth (1 yr): -8.5%** (3-yr -19.5%/yr, 5-yr 2.7%/yr). Revenue fell 8.5% over the last year, against 2.7% a year compounded over five years: growth is slowing.
- **EPS growth (1 yr): 35.6%**. Earnings per share rose 35.6%, faster than revenue, so margins expanded or the share count shrank.
- **Free-cash-flow growth (3 yr): -26.0%/yr**. Free cash flow has compounded at -26.0% a year over three years.

## Financial health
- **Debt to equity: 1.19**. Debt is 1.19 times equity, a leveraged balance sheet that needs steady cash flow to service.
- **Net debt / EBITDA: 2.1×**. It would take 2.1 years of operating earnings to repay net borrowings, within the comfortable range.
- **Altman Z-score: 2.19**. A Z-score of 2.19 is in the grey zone; not distressed, not clearly safe.
- **Piotroski F-score: 5/9**. 5 of 9 checks pass: mixed.

## Dividends
- **Dividend: none**. AMN Healthcare Services Inc does not currently pay a dividend.

## Analyst view
- **Analyst consensus: hold** (7 analysts). 7 analysts cover AMN Healthcare Services Inc; the consensus is hold, with an average price target of $35.57 (+5% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 67.1%** (YTD 114.5%, 3-mo 6.7%). The shares are up 67.1% over twelve months including dividends.
- **From 52-week high: -9.2%** (125.8% above the low). Trading 9% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 49**. An RSI of 49 is neutral.
- **Beta (1 yr): 0.93** (volatility 68%). Beta of 0.93 against the S&P 500: the shares move roughly with the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=AMN · Page: https://foliofundamentals.com/stocks/amn

Not investment advice.